KSM-66 Ashwagandha may be one of the best supplements on the market to aid in quitting vaping and quitting smoking, and with good reason.
In today's article we are going to take a deep dive into the benefits of KSM-66 Ashwagandha and let you be the judge.
What Is KSM-66 Ashwagandha?
Ashwagandha is an herb that has been used in Ayurvedic medicine for centuries.
But not all forms of Ashwagandha are created equal.
KSM-66 Ashwagandha is a branded form of ashwagandha extract that is standardized to contain a high concentration of bioactive compounds known as withanolides.
KSM-66 is one of the most popular and well-researched forms of ashwagandha extract available on the market.
KSM-66 Ashwagandha is created via a process that took 14 years of research and development and has been evaluated in over 24 published "Gold Standard" clinical trials.
KSM-66 Ashwagandha is one of the primary ingredients found inside each piece of KickIt Crave-Less chewing gum.
Why KSM-66 Ashwagandha For Quitting Nicotine?
KSM-66 Ashwagandha has been shown to mimic some of the pleasurable effects of nicotine without the downsides of nicotine addiction.
Nicotine prevents the breakdown of acetylcholine in the brain, hence why people like nicotine for its nootropic effects.
Acetylcholine plays a role in many cognitive functions including memory, focus, and learning.
KSM-66 has been shown to modulate acetylcholine function in the brain!
One study published in the journal Phytotherapy Research investigated the effects of an ashwagandha root extract on cognitive function in humans.
The results showed that participants who received the ashwagandha extract demonstrated significant improvements in cognitive function, including memory and attention, compared to those who received a placebo.
While this study did not directly measure acetylcholine levels, the observed cognitive improvements suggest potential benefits for acetylcholine-related pathways.
"Brain fog" when quitting nicotine is a commonly reported symptom of nicotine withdrawal, and can be very annoying.
Brain fog is hypothesized to be the result of blood sugar imbalance, disruption of the fight or flight neurotransmitters, and the bodies increased stress response during the nicotine withdrawal and detox period.
All things that KSM-66 has been shown to have a positive impact on.
Could something that helps with memory, focus, and attention (KSM-66) be a possible benefit to someone going though nicotine withdrawal while quitting vaping or smoking?
You decide.
KSM-66 has also been shown to lightly simulate the dopamine, GABA, and adrenaline pathways.
- Dopamine motivates us
- Adrenaline stimulates us
- GABA relaxes us
This stimulation of the three pathways can provide an alert yet relaxed effect on the user, very similar to nicotine.
Studies have suggested that ashwagandha may help protect dopamine-producing neurons from damage and degeneration, potentially preserving dopamine levels and function in the brain.
Anytime we abuse a drug in excess, (including nicotine) the outcome will be a down regulation of dopamine in the brain.
This is in part why people looking to quit nicotine can't seem to find the "motivation" to do so!
As If That Is Not Enough Of A Reason For KSM-66
KSM-66 Ashwagandha has some other appealing traits for those looking to kick their nicotine addiction to the curb.
Lung health is a common concern among those who smoke or vape, with good reason too! Your lungs keep you alive.
KSM-66 Ashwagandha has been shown to improve cardiorespiratory endurance in healthy athletic adults.
KSM-66 improved the amount of oxygen the body can use during exercise (V02max).
Sounds like a benefit someone who had a history of smoking or vaping may be interested in.
What About Weight Gain After Quitting Nicotine?
Overindulging in snacks and gaining weigh is a commonly expressed fear among those quitting nicotine.
KSM-66 may have you covered.
KSM-66 has been clinically shown to reduce cortisol levels (a fat storage hormone) and aid in the maintenance of a healthy weight.
This benefit of KSM-66 could be particularly important for those going through nicotine detox.
Nicotine detox has been correlated with an increased stress response and coinciding spike in cortisol.
Sounds beneficial right?
If That Does Not Have You Convinced This Might
One of the biggest reasons for nicotine relapse reported by people is stress.
Stress can wreak havoc on the body. Stress can result in weight pain, insomnia, increased body pain, binge eating, depression, and anxiety.
When quitting nicotine your body is under stress! The physical and psychological stress of detoxing nicotine.
Not to mention the stress of day to day life where even the smallest of things seem to be unmanageable while quitting.
KSM-66 Ashwagandha has been show to help not only mitigate stress but also help improve a persons tolerance for stress!
You read that correctly, KSM-66 helps to increase a persons stress tolerance!
Improved stress tolerance can result in everything from improved sleep, to less anxiety day to day.
This is just a few of the many benefits KSM-66 may have for those looking to quit smoking or quit vaping nicotine products.
Can It Get Any Better?
Each piece of KickIt Crave-Less chewing gum contains 50mg's of KSM-66 as an active ingredient.
50mg's may not sound like a lot. . .
BUT. . .
When used as directed, KickIt Crave-Less gum provides buccal absorption of the active ingredients bypassing breakdown in the liver and gut.
This means maximal fast acting potency and absorption of the KSM-66.
Nicotine carvings can hit hard and fast, but so does the KSM-66 in KickIt Crave-Less gum!
Not to mention chewing gum also addresses the pesky oral fixation obsession many of us vapers, smokers, and dippers face.
Are you ready to KickIt?
Dr. Frank Michalski (DC, CFMP, CARC)
Sources
(Source: Choudhary, D., Bhattacharyya, S., & Joshi, K. (2017). Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract. Phytotherapy Research, 31(2), 193–199.)
(Source: Kuboyama, T., Tohda, C., & Komatsu, K. (2014). Neuritic regeneration and synaptic reconstruction induced by withanolide A. British Journal of Pharmacology, 171(11), 2695–2706.)
(Source: Kuboyama, T., Tohda, C., & Komatsu, K. (2014). Neuritic regeneration and synaptic reconstruction induced by withanolide A. British Journal of Pharmacology, 171(11), 2695–2706.)
(Source: Kuboyama, T., Tohda, C., & Komatsu, K. (2014). Neuritic regeneration and synaptic reconstruction induced by withanolide A. British Journal of Pharmacology, 171(11), 2695–2706.)
(Source: Kuboyama, T., Tohda, C., & Komatsu, K. (2014). Neuritic regeneration and synaptic reconstruction induced by withanolide A. British Journal of Pharmacology, 171(11), 2695–2706.)
